Salute e Benessere

Navigating the Alzheimer's Disease Burden: A Comprehensive Epidemiology Study &…

Representation of Alzheimer's Disease Death Rate Worldwide Representation of Alzheimer's Disease Death Rate Worldwide The 5 stages of Alzheimer's presents a significant public health concern, with a growing global impact. According to the World Health Organization (WHO), Alzheimer's is the most common cause of dementia, accounting for approximately 60-70% of dementia cases (prevagen memory loss). The global death rate due to Alzheimer's Disease has been steadily rising, with an estimated 1...
PR Newswire
07/09/2023

Silony Medical acquires Centinel Spine's Global Fusion Business

"Adding Centinel's Fusion Products to Silony's portfolio significantly strengthens our technological and geographic footprint, without cannibalizing products and sales regions" said Silony CEO Constantin Schoen. "Uniting stand-alone/screw integrated cervical and lumbar solutions with our predominantly posterior capabilities is a logical move, that will further accelerate our global growth" "Adding Centinel's Fusion Products to Silony's portfolio significantly strengthens…
PR Newswire
07/09/2023

Oncolytics Biotech® Announces Full Exercise of Over-Allotment Option from Public…

The Offering is being made by way of a prospectus supplement to the Company's short form base shelf prospectus filed on August 1, 2023 in each of the provinces and territories of Canada, except Quebec, pursuant to National Instrument 44-101 – Short Form Prospectus Distributions and National Instrument 44-102 - Shelf Distributions. The Offering is being made by way of a prospectus supplement to the Company's short form base shelf prospectus filed onAugust 1, 2023in each of the provinces and...
PR Newswire
07/09/2023

British Skincare Brand ZELENS Hosts First Brand Ceremony in China, Setting the…

Founded by the internationally recognized as a global authority on skin ageing and skin cancer, Dr. Marko Lens, ZELENS has redefined skincare with its innovative approach. Dr. Lens, a Harvard and Oxford-educated medical professional with nearly two decades of clinical experience, established ZELENS with a mission to scientifically care for the skin. The brand embodies the culmination of years of skin science research, merging cutting-edge biotechnology with the power of natural botanicals to…
PR Newswire
07/09/2023

Fashion X AI: AiDLab unveils the trailblazing future of AI and design in London…

Launched in Hong Kong in February 2023, the Fashion X AI touring exhibition has travelled from Hong Kong to London, presenting a broad range of AI-empowered design solutions. The exhibition is a vibrant collection of works from both international and Hong Kong innovators in creative design. The exhibits include AI-assisted fashion designs, eyewear designed with 3D head scanning, and intelligent textiles that react to human gestures, etc. The Fashion X AI touring exhibition highlights the…
PR Newswire
07/09/2023

With Increasing Legal Acceptance Global Cannabis Market Projected To Reach $51…

Statista added: "The Medical Cannabis market includes cannabinoid-based medicine, either licensed or unlicensed, which is supplied through the healthcare system and prescribed by a doctor with the primary focus of mitigating serious disease symptoms. It can include higher tetrahydrocannabinol (THC) levels of cannabidiol (CBD). The Therapeutic Cannabis market covers cannabinoid-based therapeutic products with low THC levels. These products are used for medicinal purposes and are intended to…
PR Newswire
07/09/2023

Switzerland's Anti-aging Pioneer Nescens is Set to Enter a New Phase of Growth…

The event commenced with a dance performance, followed by holographic projections that provided the audience with an immersive experience. Together with Professor Jacques Proust, the founder of Nescens，the attendees including KOLs, representatives of MCN agencies, and channel distributors were introduced to Nescens' ingenious innovation and approach to anti-aging that changes the way people can maintain and repair their skin. The event commenced with a dance performance, followed by…
PR Newswire
07/09/2023

Clarius Applauded by Frost & Sullivan with the Company of the Year Award for Its…

Clarius offers seven ultrasound probes for medical use and three for veterinary use, enhancing human and animal lives. To cater to the healthcare industry's needs, the ultrasound vendor provides ultraportable wireless handheld systems with superior image quality for clinicians to utilize across settings and applications at an affordable price point, making it a top choice for budget-conscious medical institutions and health systems that do not want to sacrifice quality for cost. Its accurate…
PR Newswire
07/09/2023

Carrick Therapeutics Announces U.S. FDA Clearance of IND for CT7439, a…

/13 (CDK12/13) inhibitor. The Company plans to initiate the Phase 1 clinical trial in the first half of 2024 and intends to enroll patients with advanced solid tumors, including breast, ovarian and Ewing's Sarcoma.“FDA clearance of our IND application for CT7439, Carrick's second therapeutic candidate, further strengthens our oncology pipeline and will allow us to evaluate how our promising preclinical data translate into clinical benefits in patients with solid tumors,” said Tim Pearson,...
Nasdaq GlobeNewswire
07/09/2023

TeraRecon Applauded by Frost & Sullivan for Solving Time-related Challenges in…

TeraRecon offers Intuition, an advanced visualization imaging solution; Eureka Clinical AI, an AI-based platform for coordinated care; and TR Neuro and Neuro Suite, AI-based solutions for neurovascular conditions. Its vendor-neutral solutions provide simplified workflows and actionable insights. TeraRecon's Neuro Suite isan exhaustive and advanced AI-driven clinical suite, purpose-built for providing the physician with insights, and care activation in many neurological condition states. The…
PR Newswire
07/09/2023

Philips reaches resolution of US economic loss litigation

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) announced today that the company and certain of its US subsidiaries, including Philips Respironics, have reached an agreement to resolve all economic loss claims in the US Multidistrict Litigation (MDL) related to Philips Respironics' voluntary recall of certain sleep and respiratory care devices. This settlement, which is expected to be submitted to the US District Court for the Western District of Pennsylvania later...
Nasdaq GlobeNewswire
07/09/2023

Decking and Railing Market to Reach $18.1 Billion, Globally, by 2032 at 5.8%…

Get Inside Scoop Of The Report, Request For Sample: https://www.alliedmarketresearch.com/request-sample/180022 Get Inside Scoop Of The Report, Request For Sample: https://www.alliedmarketresearch.com/request-sample/180022 Decking and railing are two essential components in the construction and design of outdoor spaces, providing a functional and visually appealing environment for relaxation and entertainment. They are often selected based on factors such as durability, maintenance...
PR Newswire
07/09/2023

Neoss® Group announces the launch of a new Multi-Unit Abutment with their…

With a focus on predictability, efficiency, esthetics, and affordability, Neoss4+ Treatment Solution empowers the clinician to provide their patients with three treatment options depending on the clinical situation and their preference, Multi-Unit, NeoBase (Neoss version of TiBase) and Access Abutments. The new Multi-Unit Abutment comes with exclusive features thanks to key Neoss patents, which makes it possible for a 10˚ option with lower vertical height and with the clinical screw fixed…
PR Newswire
07/09/2023

INNODEM NEUROSCIENCES SIGNS A STRATEGIC COMMERCIAL FRAMEWORK AGREEMENT WITH…

This commercial agreement follows the favorable results of the observational trial involving people living with multiple sclerosis (MS). The peer reviewed performance data, which are the subject of a publication in Frontiers in Neurology, can be accessed here: https://www.frontiersin.org/articles/10.3389/fneur.2023.1243594/abstract. The promising data indicates that EMBs and GMBs may have the potential to assist healthcare professionals in detecting subtle signs of clinically significant disease…
PR Newswire
07/09/2023

Roche and Alnylam report positive topline results from Phase 2 study KARDIA-1 of…

Zilebesiran met primary endpoint demonstrating greater than 15 mmHg reduction of systolic blood pressure at three months of treatment compared to placebo Study met key secondary endpoints showing consistent and sustained reductions of systolic blood pressure at six monthsZilebesiran demonstrated an encouraging safety and tolerability profile in adult patients with mild-to-moderate hypertensionFull study results to be presented at an upcoming scientific conferenceBasel, 7...
Nasdaq GlobeNewswire
07/09/2023

PCI Biotech: European patent for mRNA delivery with fimaNAc

NActechnology. This application is primarily foreseen to be used for dermatology. Nucleic acid therapeutics, including mRNAs, have the potential to improve the treatment of dermatological diseases, but delivery to skin lesions remains an obstacle. This is a challenge PCI Biotech's fima NActechnology is uniquely positioned to solve, by light-directed intracellular nucleic acid delivery.The European patent secures protection until 2039 and this patent application is pending in the US...
Nasdaq GlobeNewswire
07/09/2023

Neuroplast successfully completes patient inclusion of Phase II clinical trial…

Double-blinded, randomized, placebo-controlled multi-center study Double-blinded, randomized, placebo-controlled multi-center study The trial was conducted by Principal InvestigatorsAntonio Oliviero, MD, PhD and Prof. Jörg Mey from Hospital Parapléjicos in Toledo,Spain, as well as Professor Fin Biering-Sørensen and MD, PhD Claus Andersen from Rigshospitalet inCopenhagen, Denmark. The study is a randomized, double-blinded and placebo-controlled trial, with an early and late...
PR Newswire
07/09/2023

OD-OS GmbH at ESCRS 2023: Recent MDR certification of Navilas® underlines its…

- Picture is available at AP - - Picture is available atAP- Dr.Winfried Teiwes, Managing Director, OD-OS GmbH:"We are very proud to have passed this important quality review of our processes and products. This confirms the high standards of our image-guided laser platform and enables us to develop future solutions to treat retinal diseases based on our unique navigation technology. We will continue to provide patients and our users in clinics and practices with more comfortable,...
PR Newswire
07/09/2023

Curium Announces Exclusive Distribution Agreement in Switzerland with b.e…

18 F) formerly known as ( 18 F)-DCFPyL), indicated for the detection of prostate-specific membrane antigen (PSMA) positive lesions with positron emission tomography in adults with prostate cancer. Under the terms of the agreement, b.e. Imaging will be responsible for obtaining marketing authorization from Swiss competent authority Swissmedic, and will have exclusive distribution rights for PYLCLARI™ across Switzerland. Dr. Michel Wuillemin, Head of Radiopharmaceuticals at b.e. Imaging...
Nasdaq GlobeNewswire
07/09/2023

Ohh-Med Medical Launches Ohh-Med UK to expand the worldwide reach of Vertica…

The company began sales of Vertica in the beginning of 2022 and received the CE-MDR approval to market throughout the EU in December of the same year. The company markets its product in Israel direct to consumers through its online shop and dedicated Call centre, and in Europe through a growing network of distributors. The company began sales of Vertica in the beginning of 2022 and received the CE-MDR approval to market throughout the EU in December of the same year. The company markets its...
PR Newswire
07/09/2023

Israel's largest healthcare provider to use Sectra's digital pathology solution…

The solution was sold by Sectra's distribution partner in Israel, VaRay Oncology Systems, to Clalit Health Services, a healthcare network encompassing nine sites and serving over 4.9 million members. The solution was sold by Sectra's distribution partner inIsrael, VaRay Oncology Systems, to Clalit Health Services, a healthcare network encompassing nine sites and serving over 4.9 million members. The contract, signed inAugust 2023, includes Sectra's digital pathology solution and...
PR Newswire
07/09/2023

iSTAR Medical presents positive three-year results for MINIject® from…

For immediate release iSTAR Medical presentspositivethree-year results for MINIject ® fromSTAR-GLOBALtrialInterim three-year follow-up data further demonstrate consistent safety and efficacy ofMINIject ®in open angle glaucoma patients WAVRE, Belgium — 7 September2023 :iSTAR Medical, a medtech company delivering breakthrough eye care solutions to patients, today announces positive three-year data from the...
Nasdaq GlobeNewswire
07/09/2023

Launch of We Venture Capital

Through a global reach, We Venture Capital invests primarily in Series A, and may also invest in Seed or Series B. With an early-stage focus, investments target start-ups close to market, or early market entrants ready to scale up. Through a global reach, We Venture Capital invests primarily in Series A, and may also invest in Seed or Series B. With an early-stage focus, investments target start-ups close to market, or early market entrants ready to scale up. We Venture Capital actively...
PR Newswire
07/09/2023

Ariceum Therapeutics doses first patient with its first-in-class targeted…

'Theranostics' is the approach of using two paired drugs – the first, a diagnostic agent to identify cells which exhibit a particular biomarker; and the second, a therapeutic drug, to act on those cells. Both the diagnostic agent and therapeutic drug contain Ariceum's proprietary peptide satoreotide, a first-in-class and best-in-class antagonist of the somatostatin receptor 2 (SST2), a cell surface protein often overexpressed in certain cancers including small cell lung cancer (SCLC). ...
PR Newswire
07/09/2023
Altri  Comunicati